Patents by Inventor Camella Bailey
Camella Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6913907Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.Type: GrantFiled: July 29, 2002Date of Patent: July 5, 2005Assignee: Human Genome Sciences, Inc.Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
-
Publication number: 20050043528Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.Type: ApplicationFiled: August 6, 2004Publication date: February 24, 2005Applicant: Human Genome Sciences, Inc.Inventors: Gil Choi, Camella Bailey, Alex Hromockyj, Charles Kunsch
-
Publication number: 20040265962Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.Type: ApplicationFiled: April 14, 2004Publication date: December 30, 2004Applicant: Human Genome Sciences, Inc.Inventors: Camella Bailey, Gil H. Choi
-
Patent number: 6753149Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.Type: GrantFiled: May 6, 2002Date of Patent: June 22, 2004Assignee: Human Genome Sciences, Inc.Inventors: Camella Bailey, Gil H. Choi
-
Publication number: 20030186364Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.Type: ApplicationFiled: May 6, 2002Publication date: October 2, 2003Applicant: Human Genome Sciences, Inc.Inventors: Camella Bailey, Gil H. Choi
-
Publication number: 20030017495Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.Type: ApplicationFiled: July 29, 2002Publication date: January 23, 2003Applicant: Human Genome Sciences, Inc.Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
-
Patent number: 6448043Abstract: The present invention relates to a novel gene from E. faecalis, EF040, and the encoded polypeptides. Also provided are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis EF040 polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus EF040 nucleic acids, encoded polypeptides and anti-EF040 antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.Type: GrantFiled: May 4, 1998Date of Patent: September 10, 2002Assignee: Human Genome Sciences, Inc.Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
-
Patent number: 6403337Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.Type: GrantFiled: February 24, 2000Date of Patent: June 11, 2002Assignee: Human Genome Sciences, Inc.Inventors: Camella Bailey, Gil H. Choi
-
Publication number: 20020045737Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.Type: ApplicationFiled: May 4, 1998Publication date: April 18, 2002Applicant: HUMAN GENOME SCIENCES, INC.Inventors: GIL H. CHOI, CAMELLA BAILEY, ALEX HROMOCKYJ, CHARLES A. KUNSCH